BridgeMD
New treatment option for Stroke
Official title The Effects of the Control Strategies of Wearable Lower Limb Rehabilitation Robots
ClinicalTrials.gov ID: NCT07037849
What this study is testing
- What it's testing
- Post-stroke patients were required to complete a session of robot-assisted training, which involved nine repetitions of 5-meter overground walking (three trials for each of the three controllers) in a rectangular hospital corridor.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Stroke patients aged between 18 and 75 years. Patients who are medically stable and able to stand and walk independently for at least 10 meters...
- Stroke event occurred at least 3 months ago Patients with impaired lower limb motor function but with some degree of muscle activity in the lower...
- Patients without severe cognitive impairment and capable of understanding and following the treatment protocol.
- Patients without severe balance or coordination disorders, able to maintain balance and perform gait training with assistive devices.
- Patients without lower limb fractures or other serious skeletal issues affecting the lower limbs.
You likely can't join if
- Severe cognitive impairment that prevents the patient from understanding or complying with the treatment protocol.
- Severe balance or coordination disorders that prevent the patient from maintaining balance and participating in gait training, even with assistive...
- Other serious motor disorders, such as abnormal muscle tone or ataxia, which may interfere with the how well it works of rehabilitation therapy.
- Active cardiovascular disease or other serious systemic illnesses that may affect the patient's safety or treatment outcomes.
- Lower limb fractures or other serious skeletal issues that may impact the suitability and safety of robot-assisted rehabilitation therapy.
- Patients currently receiving other rehabilitation or experimental treatments. Patients with skin ulcers, infections, or other severe skin conditions...
See the full eligibility criteria
- Stroke patients aged between 18 and 75 years. Patients who are medically stable and able to stand and walk independently for at least 10 meters during rehabilitation.
- Stroke event occurred at least 3 months ago Patients with impaired lower limb motor function but with some degree of muscle activity in the lower extremities.
- Patients without severe cognitive impairment and capable of understanding and following the treatment protocol.
- Patients without severe balance or coordination disorders, able to maintain balance and perform gait training with assistive devices.
- Patients without lower limb fractures or other serious skeletal issues affecting the lower limbs.
- Patients without severe cardiovascular or other serious illnesses and able to tolerate the intensity and duration of rehabilitation therapy.
- Patients willing to participate in the study and able to provide written informed consent.
- Severe cognitive impairment that prevents the patient from understanding or complying with the treatment protocol.
- Severe balance or coordination disorders that prevent the patient from maintaining balance and participating in gait training, even with assistive devices.
- Other serious motor disorders, such as abnormal muscle tone or ataxia, which may interfere with the how well it works of rehabilitation therapy.
- Active cardiovascular disease or other serious systemic illnesses that may affect the patient's safety or treatment outcomes.
- Lower limb fractures or other serious skeletal issues that may impact the suitability and safety of robot-assisted rehabilitation therapy.
- Patients currently receiving other rehabilitation or experimental treatments. Patients with skin ulcers, infections, or other severe skin conditions that may interfere with the use and application of robotic devices.
- Unexplained discomfort or pain symptoms that may limit the patient's ability to participate in rehabilitation therapy.
- Failure to meet other specific inclusion criteria outlined in the study protocol.
The study team makes the final eligibility decision.
Where it's taking place
- Shenzhen, Guangzhou, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shenzhen, Guangzhou, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.